Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Mefloquine-Artesunate in Pregnant Women with Malaria
NCT00701961Phase 3Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Oct 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of artesunate + mefloquine in Plasmodium falciparum malaria (2 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Pharmacokinetics of MQ-AS at 6 months. Started Oct 2008; status: completed.
02
Drugs
artesunate + mefloquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00701961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701961.